The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration

The treatment of liver fibrosis has clinical limitations because of its multiple etiologies, such as epithelial–mesenchymal transition (EMT) promotion, cell regeneration and remodeling dysfunction, inflammatory cell activation, and scar tissue deposition. These factors might be considered as a new t...

詳細記述

保存先:
書誌詳細
出版年:Front Pharmacol
主要な著者: Chuang, Hong-Meng, Su, Hong-Lin, Li, Chien, Lin, Shinn-Zong, Yen, Ssu-Yin, Huang, Mao-Hsuan, Ho, Li-Ing, Chiou, Tzyy-Wen, Harn, Horng-Jyh
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2016
主題:
Pharmacology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847481/
https://ncbi.nlm.nih.gov/pubmed/27199755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00112
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料